Literature DB >> 6192284

Histidinaemia. Part I: Reconciling retrospective and prospective findings.

C R Scriver, H L Levy.   

Abstract

We reach the conclusion that histidinaemia in the typical form (autosomal recessive impairment of L-histidine ammonia lyase activity (EC4.3.1.3)) is not a 'disease' in man. Retrospective and prospective studies (Rosenmann et al., 1983; Coulombe et al., 1983) together indicate that the prevalence of disadaptive phenotypes (e.g. impaired intellectual or speech development, seizures, behavioural or learning disorder) in the histidinaemia population, is not higher than the frequency of these functional disorders in the non-histidinaemia population. However, one cannot exclude the possibility that histidinaemia is a risk factor for development of an unfavourable CNS phenotype, in particular individuals under specific circumstances (e.g. abnormal perinatal events). From this viewpoint, we propose that newborn screening for early diagnosis and treatment of histidinaemia does not meet the criteria for a public health service. Screening for continuing research on histidinaemia remains justifiable, for example, to discern whether there are atypical forms of the biochemical and enzymatic phenotypes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192284     DOI: 10.1007/bf02338970

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

1.  Routine newborn screening for histidinemia. Clinical and biochemical results.

Authors:  H L Levy; V E Shih; P M Madigan
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

2.  Is hereditary histidinaemia harmful?

Authors:  J S Popkin; C L Clow; C R Scriver; J Grove
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

3.  Histidinaemia. Part III: Impact; a prospective study.

Authors:  J T Coulombe; B L Kammerer; H L Levy; B Z Hirsch; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

4.  Intellectual development in patients with untreated histidinemia. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan.

Authors:  K Tada; H Tateda; S Arashima; K Sakai; T Kitagawa; K Aoki; S Suwa; M Kawamura; T Oura; M Takesada; Y Kuroda; F Yamashita; I Matsuda; H Naruse
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

Review 5.  Phenylketonuria: epitome of human biochemical genetics (first of two parts).

Authors:  C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

6.  Histidinaemia. Part II: Impact; a retrospective study.

Authors:  A Rosenmann; C R Scriver; C L Clow; H L Levy
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

  6 in total
  9 in total

1.  Mini-symposium: newborn screening for inborn errors of metabolism--clinical effectiveness.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

2.  The control of 5-hydroxytryptamine and dopamine synthesis in the brain: a theoretical approach.

Authors:  F A Hommes; J S Lee
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia.

Authors:  F A Hommes
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 4.  Clinical biochemistry of the neonatal period: immaturity, hypoxia, and metabolic disease.

Authors:  R A Harkness
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

5.  Molecular characterization of histidinemia: identification of four missense mutations in the histidase gene.

Authors:  Yoko Kawai; Akihiko Moriyama; Kiyofumi Asai; Carrie M Coleman-Campbell; Satoshi Sumi; Hideko Morishita; Mariko Suchi
Journal:  Hum Genet       Date:  2005-01-27       Impact factor: 4.132

6.  Histidinaemia. Part II: Impact; a retrospective study.

Authors:  A Rosenmann; C R Scriver; C L Clow; H L Levy
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

7.  Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine.

Authors:  B Lemieux; C Auray-Blais; R Giguère; D Shapcott; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

8.  Neonatal encephalopathy plasma metabolites are associated with neurodevelopmental outcomes.

Authors:  Barbara D Friedes; Eleanor Molloy; Tammy Strickland; Jie Zhu; Marie Slevin; Veronica Donoghue; Deirdre Sweetman; Lynne Kelly; Mary O'Dea; Aurelie Roux; Robert Harlan; Gregory Ellis; Cedric Manlhiot; David Graham; Frances Northington; Allen D Everett
Journal:  Pediatr Res       Date:  2021-10-07       Impact factor: 3.953

9.  Spiropyran-modified upconversion nanocomposite as a fluorescent sensor for diagnosis of histidinemia.

Authors:  Jian Su; Yiwei Li; Wen Gu; Xin Liu
Journal:  RSC Adv       Date:  2020-07-16       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.